Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Practice Resource Library
Optimizing First-Line Management of Metastatic Hormone-Sensitive Prostate Cancer
The AUA collaborated with Astellas and Pfizer Oncology to assess current practice patterns related to utilization combination therapy as first-line treatment for metastatic hormone-sensitive prostate cancer (mHSPC). This practice resource provides insights into current barriers and best practices to optimal utilization of combination therapy for patients with mHSPC.
Integrating Biomarker and Genetic Testing for HRR Mutations into Prostate Cancer Management
The AUA collaborated with Pfizer Oncology to assess current practice patterns pertaining to germline and somatic HRRm testing for prostate cancer and to identify existing practices to improve patient care. This resource offers valuable insights for those looking to efficiently and effectively integrate biomarker and genetic testing to provide personalized care for prostate cancer patients.
Practical Strategies for the Use of Miscellaneous J Codes in Urology Practice
The AUA collaborated with Johnson & Johnson to assess current practice patterns around the use of miscellaneous J codes in urologic practice settings. This practice resource provides practical, actionable insights into current barriers to use, operational strategies to manage or overcome these barriers, and identifies best practices for efficient integration into operational workflows.
advertisement
advertisement